- JP-listed companies
- Chordia Therapeutics,Inc
- Balance sheet
Chordia Therapeutics,Inc (190A) Balance sheet
Market cap
¥8.9B
P/E ratio
-4.5x
Chordia Therapeutics discovers and develops innovative small-molecule cancer drugs that target RNA regulatory stress in cancer cells for pharmaceutical partners.
| 2021/08 | 2022/08 | 2023/08 | 2024/08 | 2025/08 | |
| Cash and cash equivalents | - | 4,255 | 4,799 | 4,330 | 2,549 |
| Total cash & short-term investments | - | 4,255 | 4,799 | 4,330 | 2,549 |
| Total current assets | - | 4,482 | 4,892 | 4,605 | 2,669 |
| Property, plant and equipment, net | - | 8 | 4 | 3 | - |
| Total non-current assets | - | 17 | 18 | 27 | 12 |
| Total assets | - | 4,499 | 4,909 | 4,632 | 2,681 |
| Total current liabilities | - | 221 | 408 | 471 | 244 |
| Total liabilities | - | 221 | 408 | 471 | 244 |
| Retained earnings | - | -4,118 | -3,895 | -5,722 | -7,508 |
| Stockholders' equity | 2,056 | 4,278 | 4,501 | 4,161 | 2,437 |